ACAD
Price
$22.10
Change
+$0.12 (+0.55%)
Updated
Jun 9, 02:09 PM (EDT)
Capitalization
3.68B
51 days until earnings call
INZY
Price
$3.98
Change
-$0.02 (-0.50%)
Updated
Jun 9, 02:38 PM (EDT)
Capitalization
257.6M
64 days until earnings call
Interact to see
Advertisement

ACAD vs INZY

Header iconACAD vs INZY Comparison
Open Charts ACAD vs INZYBanner chart's image
ACADIA Pharmaceuticals
Price$22.10
Change+$0.12 (+0.55%)
Volume$300
Capitalization3.68B
Inozyme Pharma
Price$3.98
Change-$0.02 (-0.50%)
Volume$100
Capitalization257.6M
ACAD vs INZY Comparison Chart
Loading...
ACAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACAD vs. INZY commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACAD is a StrongBuy and INZY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (ACAD: $22.02 vs. INZY: $3.95)
Brand notoriety: ACAD and INZY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACAD: 65% vs. INZY: 243%
Market capitalization -- ACAD: $3.68B vs. INZY: $257.6M
ACAD [@Biotechnology] is valued at $3.68B. INZY’s [@Biotechnology] market capitalization is $257.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $334.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACAD’s FA Score shows that 1 FA rating(s) are green whileINZY’s FA Score has 0 green FA rating(s).

  • ACAD’s FA Score: 1 green, 4 red.
  • INZY’s FA Score: 0 green, 5 red.
According to our system of comparison, ACAD is a better buy in the long-term than INZY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACAD’s TA Score shows that 5 TA indicator(s) are bullish while INZY’s TA Score has 5 bullish TA indicator(s).

  • ACAD’s TA Score: 5 bullish, 5 bearish.
  • INZY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, INZY is a better buy in the short-term than ACAD.

Price Growth

ACAD (@Biotechnology) experienced а +0.78% price change this week, while INZY (@Biotechnology) price change was +0.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.70%. For the same industry, the average monthly price growth was +19.60%, and the average quarterly price growth was +6.76%.

Reported Earning Dates

ACAD is expected to report earnings on Jul 30, 2025.

INZY is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+10.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACAD($3.68B) has a higher market cap than INZY($258M). INZY YTD gains are higher at: 42.780 vs. ACAD (20.000). ACAD has higher annual earnings (EBITDA): 100M vs. INZY (-95.72M). ACAD has more cash in the bank: 756M vs. INZY (113M). INZY has less debt than ACAD: INZY (46.9M) vs ACAD (52M). ACAD has higher revenues than INZY: ACAD (958M) vs INZY (0).
ACADINZYACAD / INZY
Capitalization3.68B258M1,426%
EBITDA100M-95.72M-104%
Gain YTD20.00042.78047%
P/E Ratio16.04N/A-
Revenue958M0-
Total Cash756M113M669%
Total Debt52M46.9M111%
FUNDAMENTALS RATINGS
ACAD: Fundamental Ratings
ACAD
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
25
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACADINZY
RSI
ODDS (%)
Bearish Trend 13 days ago
58%
Bearish Trend 13 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 13 days ago
63%
Bearish Trend 13 days ago
85%
Momentum
ODDS (%)
Bullish Trend 13 days ago
78%
N/A
MACD
ODDS (%)
N/A
Bullish Trend 13 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 13 days ago
74%
Bullish Trend 13 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 13 days ago
78%
Bullish Trend 13 days ago
86%
Advances
ODDS (%)
Bullish Trend 14 days ago
73%
Bullish Trend 22 days ago
87%
Declines
ODDS (%)
Bearish Trend 21 days ago
73%
Bearish Trend about 1 month ago
90%
BollingerBands
ODDS (%)
Bearish Trend 13 days ago
79%
Bearish Trend 13 days ago
90%
Aroon
ODDS (%)
Bullish Trend 13 days ago
76%
Bullish Trend 13 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ACAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ACAD and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACAD has been loosely correlated with INZY. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ACAD jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACAD
1D Price
Change %
ACAD100%
-0.77%
INZY - ACAD
50%
Loosely correlated
N/A
AURA - ACAD
44%
Loosely correlated
+0.17%
CRSP - ACAD
43%
Loosely correlated
-0.92%
ERAS - ACAD
40%
Loosely correlated
+1.85%
PGEN - ACAD
40%
Loosely correlated
-2.84%
More

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with ACAD. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then ACAD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
N/A
ACAD - INZY
50%
Loosely correlated
-0.77%
PRME - INZY
43%
Loosely correlated
N/A
IMTX - INZY
43%
Loosely correlated
+4.26%
KROS - INZY
43%
Loosely correlated
+2.02%
AURA - INZY
38%
Loosely correlated
+0.17%
More